0001104659-24-001167.txt : 20240104 0001104659-24-001167.hdr.sgml : 20240104 20240104085629 ACCESSION NUMBER: 0001104659-24-001167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelletier Nadege CENTRAL INDEX KEY: 0001965689 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40367 FILM NUMBER: 24509871 MAIL ADDRESS: STREET 1: C/O VACCITECH PLC, UNIT 6-10 STREET 2: ZEUS BUILDING RUTHERFORD AVENUE, HARWELL CITY: DIDCOT STATE: X0 ZIP: OX11 0DF ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Barinthus Biotherapeutics plc. CENTRAL INDEX KEY: 0001828185 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UNIT 6-10, ZEUS BUILDING STREET 2: RUTHERFORD AVENUE, HARWELL CITY: DIDCOT STATE: X0 ZIP: OX11 0DF BUSINESS PHONE: 44 (0) 1865 818808 MAIL ADDRESS: STREET 1: UNIT 6-10, ZEUS BUILDING STREET 2: RUTHERFORD AVENUE, HARWELL CITY: DIDCOT STATE: X0 ZIP: OX11 0DF FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech plc DATE OF NAME CHANGE: 20210407 FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech Ltd DATE OF NAME CHANGE: 20201014 4 1 tm241766-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-02 0 0001828185 Barinthus Biotherapeutics plc. BRNS 0001965689 Pelletier Nadege UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF UNITED KINGDOM 0 1 0 0 Chief Scientific Officer 0 Share Option (Right to Buy) 3.70 2024-01-02 4 A 0 105000 0 A 2034-01-02 Ordinary Shares 105000 105000 D The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ William Enright, Attorney-in-Fact 2024-01-04